Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Приливы как предвестники метаболических нарушений и сердечно-сосудистых рисков в климактерии: мнение эксперта
Приливы как предвестники метаболических нарушений и сердечно-сосудистых рисков в климактерии: мнение эксперта
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Елена Николаевна Андреева – профессор, доктор медицинских наук, заместитель директора Эндокринологического научного центра, директор Института репродуктивной медицины ФГБУ «НМИЦ эндокринологии».
Полный текст
Список литературы
1. Freedman RR. Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid Biochem Mol Biol 2014; 142: 115–20.
2. Archer DF, Sturdee DW, Baber R et al. Menopausal hot flushes and night sweats: where are we now? Climacteric 2011; 14: 515–28.
3. Thurston RC, Chang Y, Barinas-Mitchell E et al. Physiologically assessed hot flashes and endothelial function among midlife women. Menopause 2017; 24: 886–93.
4. Thurston RC, Sutton-Tyrell K, Everson-Rose SA et al. Hot flashes and subclinical cardiovascular disease. Findings from the Study of Women’s Health Across the Nation Heart Study. Circulation 2008; 118: 1234–40.
5. Allison MA, Manson JE, Aragaki A et al. Vasomotor symptoms and coronary artery calcium in postmenopausal women. Menopause 2010; 17: 1136–45.
6. Svartberg J, von Muhlen D, Kritz-Silverstein D, Barrett-Connor E. Vasomotor symptoms and mortality: the Rancho Bernardo Study. Menopause 2009; 16: 888–91.
7. Muka T, Oliver-Williams C, Colpani V et al. Association of vasomotor and other menopausal symptoms with risk of cardiovascular disease: a systematic review and meta-analysis. PLoS One 2016; 11: 0157417.
8. Thurston RC, Johnson BD, Shufelt CL et al. Menopausal symptoms and cardiovascular disease mortality in the Women’s Ischemia Syndrome Evaluation (WISE). Menopause 2017; 24: 126–32.
9. Herber-Gast G, Brown WJ, Mishra GD. Hot flushes and night sweats are associated with coronary heart disease risk in midlife: a longitudinal study. BJOG 2015; 122: 1560–7.
10. Franco OH, Muka T, Colpani V et al. Vasomotor symptoms in women and cardiovascular risk markers: systematic review and meta-analysis. Maturitas 2015; 81: 353–61.
11. Thurston RC, El Khoudary SR, Sutton-Tyrrell K et al. Vasomotor symptoms and insulin resistance in the Study of women's health across the nation. J Clin Endocrinol Metab 2012; 97: 3487–94.
12. Jackson EA, El Khoudary SR, Crawford SL et al. Hot flash frequency and blood pressure: data from the Study of Women's Health across the Nation. J Womens Health 2016; 25: 1204–9.
13. Silveira JS, Clapauch R, Souza M, Bouskela E. Hot flashes: emerging cardiovascular risk factors in recent and late postmenopause and their association with higher blood pressure. Menopause 2016; 23: 846–55.
14. Tuomikoski P, Ylikorkala O, Mikkola TS. Menopausal hot flushes and vascular health. Ann Med 2011; 43: 283–91.
15. Hitchcock CL, Elliott TG, Norman EG et al. Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women. Menopause 2012; 19: 1208–14.
16. Клинические рекомендации по ведению больных с метаболическим синдромом. М., 2013.
17. Gray KE, Katon JG, LeBlanc ES et al. Vasomotor symptom characteristics: are they risk factors for incident diabetes? Menopause 2018; 25 (5): 520–30.
18. Sturdee DW, Hunter MS, Maki PM et al. The menopausal hot flush: a review. Climacteric 2017; 20 (4): 296–305.
19. Schindler AE et al. Maturitas 2003; 46 (Suppl. 1): S7–S16;
20. Rŭbig A. Climacteric. 2003; 6 (Suppl. 3): 49–54.
21. Rizzo MR, Leo S, De Franciscis P et al. Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome. Age (Dordr) 2013; 36 (1): 265–74.
22. Dinger J et al. Drospirenone plus estradiol and the risk of serious cardiovascular events in postmenopausal women. Climacteric 2016; 19 (4): 349–56.
23. Григорян О.Р., Андреева Е.Н. Состояние углеводного обмена у женщин в период менопаузы. Сахарный диабет. 2009; 4: 15–20.
24. Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: Randomised trial. BMJ 2012; 345:6409.
2. Archer DF, Sturdee DW, Baber R et al. Menopausal hot flushes and night sweats: where are we now? Climacteric 2011; 14: 515–28.
3. Thurston RC, Chang Y, Barinas-Mitchell E et al. Physiologically assessed hot flashes and endothelial function among midlife women. Menopause 2017; 24: 886–93.
4. Thurston RC, Sutton-Tyrell K, Everson-Rose SA et al. Hot flashes and subclinical cardiovascular disease. Findings from the Study of Women’s Health Across the Nation Heart Study. Circulation 2008; 118: 1234–40.
5. Allison MA, Manson JE, Aragaki A et al. Vasomotor symptoms and coronary artery calcium in postmenopausal women. Menopause 2010; 17: 1136–45.
6. Svartberg J, von Muhlen D, Kritz-Silverstein D, Barrett-Connor E. Vasomotor symptoms and mortality: the Rancho Bernardo Study. Menopause 2009; 16: 888–91.
7. Muka T, Oliver-Williams C, Colpani V et al. Association of vasomotor and other menopausal symptoms with risk of cardiovascular disease: a systematic review and meta-analysis. PLoS One 2016; 11: 0157417.
8. Thurston RC, Johnson BD, Shufelt CL et al. Menopausal symptoms and cardiovascular disease mortality in the Women’s Ischemia Syndrome Evaluation (WISE). Menopause 2017; 24: 126–32.
9. Herber-Gast G, Brown WJ, Mishra GD. Hot flushes and night sweats are associated with coronary heart disease risk in midlife: a longitudinal study. BJOG 2015; 122: 1560–7.
10. Franco OH, Muka T, Colpani V et al. Vasomotor symptoms in women and cardiovascular risk markers: systematic review and meta-analysis. Maturitas 2015; 81: 353–61.
11. Thurston RC, El Khoudary SR, Sutton-Tyrrell K et al. Vasomotor symptoms and insulin resistance in the Study of women's health across the nation. J Clin Endocrinol Metab 2012; 97: 3487–94.
12. Jackson EA, El Khoudary SR, Crawford SL et al. Hot flash frequency and blood pressure: data from the Study of Women's Health across the Nation. J Womens Health 2016; 25: 1204–9.
13. Silveira JS, Clapauch R, Souza M, Bouskela E. Hot flashes: emerging cardiovascular risk factors in recent and late postmenopause and their association with higher blood pressure. Menopause 2016; 23: 846–55.
14. Tuomikoski P, Ylikorkala O, Mikkola TS. Menopausal hot flushes and vascular health. Ann Med 2011; 43: 283–91.
15. Hitchcock CL, Elliott TG, Norman EG et al. Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women. Menopause 2012; 19: 1208–14.
16. Клинические рекомендации по ведению больных с метаболическим синдромом. М., 2013.
17. Gray KE, Katon JG, LeBlanc ES et al. Vasomotor symptom characteristics: are they risk factors for incident diabetes? Menopause 2018; 25 (5): 520–30.
18. Sturdee DW, Hunter MS, Maki PM et al. The menopausal hot flush: a review. Climacteric 2017; 20 (4): 296–305.
19. Schindler AE et al. Maturitas 2003; 46 (Suppl. 1): S7–S16;
20. Rŭbig A. Climacteric. 2003; 6 (Suppl. 3): 49–54.
21. Rizzo MR, Leo S, De Franciscis P et al. Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome. Age (Dordr) 2013; 36 (1): 265–74.
22. Dinger J et al. Drospirenone plus estradiol and the risk of serious cardiovascular events in postmenopausal women. Climacteric 2016; 19 (4): 349–56.
23. Григорян О.Р., Андреева Е.Н. Состояние углеводного обмена у женщин в период менопаузы. Сахарный диабет. 2009; 4: 15–20.
24. Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: Randomised trial. BMJ 2012; 345:6409.
Авторы
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.